| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K26531177 |
| PharmacoGx | BRD-K26531177 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EFCAB6 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | TCP11L1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | C19orf81 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | PHYHD1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | TDG | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | MAP2K1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | PTGR1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | UQCRC1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | SLC25A40 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | VSTM1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
